Industry Pushes Go-Slow Approach to Quality Metrics Reporting

Drug Industry Daily
Drugmakers and the FDA have different ideas about the proper scale for the agency’s quality metrics program. While industry supports collecting data on no more than four metrics, the FDA promises only that it will monitor no more than 16.

To View This Article:


Subscribe To Drug Industry Daily